Cargando...
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
The coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we performed this systematic review and meta-analysis to evaluate the ef...
Guardado en:
| Publicado en: | Eur J Pharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859696/ https://ncbi.nlm.nih.gov/pubmed/33549577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2021.173926 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|